Clinical Trial Update: Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating empagliflozin versus statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis is listed as not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Empagliflozin (empagliflozin)
• Statins

Snippet

Sponsor: Badr University | Conditions: Non-alcoholic Fatty Liver Disease NAFLD, Non-alcoholic Steatohepatitis NASH | Phase 4 | Status: NOT_YET_RECRUITING